MD Anderson researchers report early success of novel menin-targeted therapies in leukemia

Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.

Biotech Stocks 2024 Second Half OutlookBuy Biotechs

Biotech indexes lagged broader market indexes in the first half of 2024, and trade at the same level as in early 2022. Biotech valuations are

July 10, 2024

MarketingRx roundup: Pharmas nab ‘greenest’ awards; Gilead sponsors ESG executive conference

It is apparently easy being green if you’re a pharma company. Seventeen pharma companies made Newsweek’s first-ever list of “greenest companies,” including many of the

October 4, 2023

Showdown at Masimo: Proxy battle targets CEO Kiani’s leadership, board

Masimo Chairman and CEO Joe Kiani is about to face his toughest challenge yet as leader of the patient monitoring company he founded more than

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.